So much in here, every bit of it worth a read...the attacks on vaxxine skeptics, coverup of vaxxine injury and so much more, but there's also data from a fascinating new study of Cleveland employees. Booster effectiveness at a pathetic 23%, but check out the hazard ratio in the results section: 2.51 for those with more than 3 jabs?!?
The greater the number of jabs, the higher the risk. If people understood what this meant, there would be pitchforks.
https://open.substack.com/pub/rwmalonemd/p/update-on-covid-mrna-vaccine-harms?r=aiop6&utm_campaign=post&utm_medium=web"The final article to be discussed this upcoming Friday during the live "Fallout" broadcast has not yet passed through the "peer review" tunnel, but comes from one of the leading US medical organizations, the Cleveland Clinic. Cleveland Clinic previously published the first major report of "negative effectiveness" after repeated administration of COVID mRNA "vaccines". What the heck is "negative effectiveness" you may ask? This is a rather nuanced way of saying that, sometime after administration, those who received the "vaccine" products became MORE likely to develop COVID 19 clinical disease. Not only do the "vaccine" products not provide substantial long term protection from infection and disease, but they actually make recipients more likely to develop clinically significant COVID. Which helps make sense of why so many of the clinical trials claiming to demonstrate vaccine effectiveness are short term- they stop collecting data before the recipients slide down into the negative effectiveness side."
...
Results Among 47561 employees, COVID-19 occurred in 838 (1.8%) during the 16-week study period. In multivariable analysis, the 2023-2024 formula vaccinated state was associated with a significantly lower risk of COVID-19 while the JN.1 lineage was the dominant circulating strain (hazard ratio [HR], .77; 95% confidence interval [C.I.], .62-.94;
P = .01), yielding an estimated vaccine effectiveness of 23% (95% C.I., 6%-38%). Compared to 0 or 1 prior vaccine doses, risk of COVID-19 was incrementally higher with 2 prior doses (HR, .1.46; 95% C.I., 1.12-1.90;
P < .005), 3 prior doses (HR, 1.95; 95% C.I., 1.51-2.52;
P < .001), and more than 3 prior doses (HR, 2.51; 95% C.I., 1.91-3.31;
P < .001).